Insufficient secretion of atrial natriuretic peptide at acute phase of myocardial infarction

Journal of Applied Physiology

Volumn 89, Issue 2, 2000, Pages 458-464

  Maeda, Keiko ^a   Tsutamoto, Takayoshi ^a   Wada, Atsuyuki ^a   Mabuchi, Naoko ^a   Hayashi, Masaru ^a   Hisanaga, Tomoko ^a   Kamijo, Takeshi ^b   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Acute heart failure; Cardiac natriuretic peptides; Ischemia; Pulmonary capillary wedge pressure

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ACUTE HEART INFARCTION; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART ATRIUM PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; HORMONE BLOOD LEVEL; HORMONE DEFICIENCY; HORMONE RELEASE; HUMAN; LUNG CAPILLARY PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033883208     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.2000.89.2.458     Document Type: Article

References (30)

1. The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man
2. Effects of synthetic atrial natriuretic factor on renal function and renin release
3. Atrial natriuretic peptide elevation in congestive heart failure in the human
4. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion
5. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
6. BNP: Pathophysiological and potential therapeutic roles in acute congestive heart failure
7. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction
8. Brain natriuretic peptide is induced by alpha 1-adrenergic agonists as a primary response gene in cultured rat cardiac myocytes
9. Hemodynamic and hormonal responses to nicorandil in a canine model of acute ischemic heart failure: A comparison with cromakalim and nitroglycerin
10. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial
11. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
12. Low dose synthetic human atrial natriuretic peptide infusion in a patient with mitral stenosis and severe pulmonary hypertension
13. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction
14. Brain natriuretic peptide as a novel cardiac hormone in humans: Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide, and brain natriuretic peptide
15. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy
16. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure
17. The influence of resting tension on immunoreactive atrial natriuretic peptide secretion by rat atria superfused in vitro
18. Inhibitory effect of brain natriuretic peptide on central angiotensin II-stimulated presser response in conscious rats
19. Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarction
20. Atrial natriuretic peptide after myocardial infarction
21. Plasma atrial natriuretic polypeptide as an index of left ventricular end-diastolic pressure in patients with chronic left-sided heart failure
22. Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure
23. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure
24. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
25. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptides in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase coupled receptor
26. Effects of endogenous atrial natriuretic peptide released by rapid atrial pacing in dogs
27. Early decrease in atrial natriuretic peptide in acute myocardial infarction
28. Atrial natriuretic peptide response to rapid atrial pacing in cardiac-denervated dogs
29. Atrial natriuretic peptide inhibits cardiac hypertrophy induced by volume overload in rats with aortocaval shunt
30. Localization and mechanism of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure